Gast ::
| Hauptseite > Publikationsdatenbank > Structural Biology of Cisplatin Complexes with Cellular Targets: The Adduct with Human Copper Chaperone Atox1 in Aqueous Solution > print |
| Hauptseite > Publikationsdatenbank > Structural Biology of Cisplatin Complexes with Cellular Targets: The Adduct with Human Copper Chaperone Atox1 in Aqueous Solution > print |
| 001 | 201334 | ||
| 005 | 20210129215726.0 | ||
| 024 | 7 | _ | |a 10.1002/chem.201402834 |2 doi |
| 024 | 7 | _ | |a 0947-6539 |2 ISSN |
| 024 | 7 | _ | |a 1521-3765 |2 ISSN |
| 024 | 7 | _ | |a WOS:000341630500019 |2 WOS |
| 024 | 7 | _ | |a altmetric:2592132 |2 altmetric |
| 024 | 7 | _ | |a pmid:25111319 |2 pmid |
| 037 | _ | _ | |a FZJ-2015-03631 |
| 082 | _ | _ | |a 540 |
| 100 | 1 | _ | |0 P:(DE-Juel1)166168 |a Calandrini, Vania |b 0 |u fzj |
| 245 | _ | _ | |a Structural Biology of Cisplatin Complexes with Cellular Targets: The Adduct with Human Copper Chaperone Atox1 in Aqueous Solution |
| 260 | _ | _ | |a Weinheim |b Wiley-VCH |c 2014 |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1435066791_32631 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 520 | _ | _ | |a Cisplatin is one of the most used anticancer drugs. Its cellular influx and delivery to target DNA may involve the copper chaperone Atox1 protein. Although the mode of binding is established by NMR spectroscopy measurements in solution—the Pt atom binds to Cys12 and Cys15 while retaining the two ammine groups—the structural determinants of the adduct are not known. Here a structural model by hybrid Car–Parrinello density functional theory-based QM/MM simulations is provided. The platinated site minimally modifies the fold of the protein. The calculated NMR and CD spectral properties are fully consistent with the experimental data. Our in silico/in vitro approach provides, together with previous studies, an unprecedented view into the structural biology of cisplatin–protein adducts. |
| 536 | _ | _ | |0 G:(DE-HGF)POF2-899 |a 899 - ohne Topic (POF2-899) |c POF2-899 |x 0 |f POF I |
| 588 | _ | _ | |a Dataset connected to CrossRef, juser.fz-juelich.de |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Nguyen, Trung Hai |b 1 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Arnesano, Fabio |b 2 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Galliani, Angela |b 3 |
| 700 | 1 | _ | |0 P:(DE-Juel1)146009 |a Ippoliti, Emiliano |b 4 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)145614 |a Carloni, Paolo |b 5 |e Corresponding Author |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Natile, Giovanni |b 6 |
| 773 | _ | _ | |0 PERI:(DE-600)1478547-x |a 10.1002/chem.201402834 |g Vol. 20, no. 37, p. 11719 - 11725 |n 37 |p 11719 - 11725 |t Chemistry - a European journal |v 20 |x 0947-6539 |y 2014 |
| 909 | C | O | |o oai:juser.fz-juelich.de:201334 |p VDB |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)166168 |a Forschungszentrum Jülich GmbH |b 0 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)1026307295 |6 P:(DE-HGF)0 |a German Research School for Simulation Sciences |b 1 |k GRS |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)146009 |a Forschungszentrum Jülich GmbH |b 4 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)145614 |a Forschungszentrum Jülich GmbH |b 5 |k FZJ |
| 913 | 2 | _ | |0 G:(DE-HGF)POF3-574 |1 G:(DE-HGF)POF3-570 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l Decoding the Human Brain |v Theory, modelling and simulation |x 0 |
| 913 | 1 | _ | |0 G:(DE-HGF)POF2-899 |1 G:(DE-HGF)POF2-890 |2 G:(DE-HGF)POF2-800 |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |v ohne Topic |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF2 |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |
| 915 | _ | _ | |0 StatID:(DE-HGF)0110 |2 StatID |a WoS |b Science Citation Index |
| 915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
| 915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
| 915 | _ | _ | |0 StatID:(DE-HGF)1150 |2 StatID |a DBCoverage |b Current Contents - Physical, Chemical and Earth Sciences |
| 915 | _ | _ | |0 StatID:(DE-HGF)9905 |2 StatID |a IF >= 5 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-9-20140121 |k INM-9 |l Computational Biomedicine |x 0 |
| 920 | 1 | _ | |0 I:(DE-Juel1)IAS-5-20120330 |k IAS-5 |l Computational Biomedicine |x 1 |
| 920 | 1 | _ | |0 I:(DE-Juel1)GRS-20100316 |k GRS |l GRS |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)INM-9-20140121 |
| 980 | _ | _ | |a I:(DE-Juel1)IAS-5-20120330 |
| 980 | _ | _ | |a I:(DE-Juel1)GRS-20100316 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)IAS-5-20120330 |
| 981 | _ | _ | |a I:(DE-Juel1)GRS-20100316 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|